What is the current stock price of Gemina Laboratories Ltd. (GLABF)?

As of the latest market data, Gemina Laboratories Ltd. (GLABF) is trading at $0.05. The stock has seen a loss of 0.00% today.

Does Gemina Laboratories Ltd. (GLABF) pay a dividend?

Based on current data, Gemina Laboratories Ltd. does not have a confirmed active dividend policy.

What is the market cap of Gemina Laboratories Ltd.?

The current market capitalization of Gemina Laboratories Ltd. (GLABF) is approximately unavailable.

GLABF

Gemina Laboratories Ltd.·Healthcare

0.05

0.000%(+0.00)

Market Closed

0.06

15.350%(+0.01)

After Hours

Last Updated: — ET

52W L: $0.0452W H: $0.92

GLABF NEWS

accessnewswire.com

Mar 25

Gemina Laboratories Ltd. Announces Delisting from the CSE

VANCOUVER, BC / ACCESS Newswire / March 25, 2026 / Gemina Laboratories Ltd. (CSE:GLAB) ("Gemina" or the "Company") announces that that the Canadian Securities Exchange (the "CSE") has approved is application to voluntarily delist its common shares from trading on the CSE.

Company Profile

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops novel surface functionalization chemistries for the detection of pathogens and biomarkers. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. The company is headquartered in Vancouver, Canada.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2022-03-29

Beta

-0.07

Websitewww.geminalabs.com↗